. 2011 Apr 19;152(7):2797–2805. doi: 10.1210/en.2010-1247

Table 2.

Effects of treatment with epostane (EPO) and/or PGF_2α on expression of mRNA for CXCR2, CCR1, CCR2, and CCR5 in d 9 CL

mRNA	Control	EPO	PGF_2α	PGF_2α + EPO
CXCR2 (×10⁻³)	6.40 ± 1.62^a	6.99 ± 2.22^a	9.54 ± 2.37^a	15.4 ± 1.96^b
CCR1 (×10⁻³)	4.36 ± 0.50^a	5.12 ± 1.34^a	7.42 ± 1.89^a	59.5 ± 27.6^b
CCR2 (×10⁻²)	7.76 ± 1.03^a	8.08 ± 2.03^ab	15.2 ± 3.20^b	34.3 ± 6.65^c
CCR5 (×10⁻¹)	9.64 ± 2.88^a	8.50 ± 4.58^a	22.0 ± 6.53^ab	42.5 ± 13.2^b

^a,b,c

Data within each row without common superscripts are significantly different between groups (P < 0.05).